Login Logout

Key Data Points

Primary metrics and data points about Galectin Therapeutics Inc..
Current Price: $4.74
Prev Close: $4.76
Open: $4.81
Bid: $4.56
Ask: $5.25
Day's Range: $4.61 - $4.90
52wk Range: $4.28 - $19.11
Volume: 111,026
Avg Vol 201,755
Market Cap: $104M
P/E (ttm): -6.10
EPS (ttm): ($0.78)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Galectin Therapeutics Inc..

A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drugs

Stock Charting

GALT vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Galectin Therapeutics Inc..
CAPS Rating 1 out of 5
 
47 Outperform
51 Underperform
CAPS All Stars
 
8 Outperform
36 Underperform

Powered by Motley Fool CAPS


More Details about Galectin Therapeutics Inc.

Primary metrics and data points about Galectin Therapeutics Inc..

Company Photos

Powered by